Immunity against Mycobacterium ulcerans: The subversive role of mycolactone
- 19 February 2021
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 301 (1) , 209-221
Abstract
Summary: Mycobacterium ulcerans causes Buruli ulcer, a neglected tropical skin disease manifesting as chronic wounds that can leave victims with major, life‐long deformity and disability. Differently from other mycobacterial pathogens, M ulcerans produces mycolactone, a diffusible lipid factor with unique cytotoxic and immunomodulatory properties. Both traits result from mycolactone targeting Sec61, the entry point of the secretory pathway in eukaryotic cells. By inhibiting Sec61, mycolactone prevents the host cell's production of secreted proteins, and most of its transmembrane proteins. This molecular blockade dramatically alters the functions of immune cells, thereby the generation of protective immunity. Moreover, sustained inhibition of Sec61 triggers proteotoxic stress responses leading to apoptotic cell death, which can stimulate vigorous immune responses. The dynamics of bacterial production of mycolactone and elimination by infected hosts thus critically determine the balance between its immunostimulatory and immunosuppressive effects. Following an introduction summarizing the essential information on Buruli ulcer disease, this review focuses on the current state of knowledge regarding mycolactone's regulation and biodistribution. We then detail the consequences of mycolactone‐mediated Sec61 blockade on initiation and maintenance of innate and adaptive immune responses. Finally, we discuss the key questions to address in order to improve immunity to M ulcerans, and how increased knowledge of mycolactone biology may pave the way to innovative therapeutics.Keywords
Funding Information
- Institut Pasteur
- Institut National de la Santé et de la Recherche Médicale (U1221)
This publication has 116 references indexed in Scilit:
- Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans InfectionClinical Infectious Diseases, 2011
- Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expressionProceedings of the National Academy of Sciences, 2011
- Chemistry of mycolactones, the causative toxins of Buruli ulcerProceedings of the National Academy of Sciences, 2011
- Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer DiseaseThe Journal of Infectious Diseases, 2009
- Phagocytosis ofMycobacterium ulceransin the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesionsBritish Journal of Dermatology, 2009
- Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteriaNatural Product Reports, 2008
- Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactoneJournal of Experimental Medicine, 2007
- A Booster Vaccination with Mycobacterium bovis BCG Does Not Increase the Protective Effect of the Vaccine against Experimental Mycobacterium ulcerans Infection in MiceInfection and Immunity, 2007
- Total synthesis of mycolactones A and BTetrahedron, 2007
- Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcerGenome Research, 2007